Topal Firdevs, Akbulut Sabiye, Karahanlı Cengiz, Günay Süleyman, Sarıtaş Yüksel Elif, Topal Fatih Esad
Department of Gastroenterology, Katip Celebi University Ataturk Training and Research Hospital, 35360 Izmir, Turkey.
Department of Gastroenterology, University of Health Sciences, Kartal Koşuyolu High Specialty Training and Research Hospital, 34846 Istanbul, Turkey.
Gastroenterol Res Pract. 2020 Feb 26;2020:9058909. doi: 10.1155/2020/9058909. eCollection 2020.
Portal hypertensive polyps in patients with portal hypertension are described.
The most significant and serious complication in liver cirrhosis proves to be portal hypertension. Polypoid lesions, which can be seen in the stomach as endoscopic finding in patients with portal hypertension, have not quite been defined in the literature. The aim of this study, therefore, was to define polypoid lesion formation due to portal hypertension in the upper gastrointestinal system in patients with portal hypertension. . Cross-sectional study.
The study covered a group of patients with liver cirrhosis and a healthy control group that did not have portal hypertension. All individuals covered by the study received upper GI endoscopy, while the endoscopic features and pathological characteristics of the identified polypoid lesions were defined. Standard histological criteria were used in polyp diagnosis.
A total of 400 individuals were included in the study. Upper GI endoscopy was performed for 200 patients with liver cirrhosis and another 200 healthy individuals with no portal hypertension in the control group. When the cases were gastroscopically assessed with regard to polypoid lesion presence, it was seen that a total of 87 (21.8%) individuals had polyps. While 67 (33.5%) cirrhotic patients were identified to have polyps, 20 (10%) individuals in the healthy control group had polyps. When the results of those with liver cirrhosis who received esophageal variceal endoscopic band ligation (EVL) and who did not were compared, it was observed that a higher number of individuals in the group with EVL had polypoid lesions. When the patient and control groups were compared as to Helicobacter pylori presence, the results showed that it was slightly higher in the dyspepsia group but the difference was not statistically significant ( > 0.05).
Portal hypertension-associated polypoid lesions are common in advanced liver cirrhosis cases. The pathological analyses of these polyps pointed out that they were all benign and no malignant cases were detected. It was argued that these polypoid lesions, referred to as portal hypertensive polyps, were associated with elevated angiogenesis in the gastric mucosa.
描述了门静脉高压患者的门静脉高压性息肉。
肝硬化中最显著和严重的并发症是门静脉高压。门静脉高压患者胃内可见的息肉样病变在文献中尚未完全明确。因此,本研究的目的是明确门静脉高压患者上消化道系统中由门静脉高压引起的息肉样病变形成情况。横断面研究。
该研究涵盖一组肝硬化患者和一个无门静脉高压的健康对照组。研究中的所有个体均接受上消化道内镜检查,同时明确所发现息肉样病变的内镜特征和病理特征。息肉诊断采用标准组织学标准。
共有400人纳入研究。对200例肝硬化患者和对照组另外200例无门静脉高压的健康个体进行了上消化道内镜检查。在胃镜检查评估息肉样病变的存在情况时,发现共有87例(21.8%)个体有息肉。67例(33.5%)肝硬化患者被确定有息肉,而健康对照组中有20例(10%)个体有息肉。比较接受食管静脉曲张内镜套扎术(EVL)和未接受该手术的肝硬化患者的结果,发现接受EVL治疗的组中息肉样病变的个体数量更多。比较患者组和对照组幽门螺杆菌的存在情况,结果显示消化不良组略高,但差异无统计学意义(>0.05)。
门静脉高压相关的息肉样病变在晚期肝硬化病例中很常见。这些息肉的病理分析指出它们均为良性,未检测到恶性病例。有人认为这些息肉样病变,即门静脉高压性息肉,与胃黏膜血管生成增加有关。